| Renal Diseases and Glomerulopathies | Lifetime | 15 | CN 1 | 99.77 |
| Chronic Kidney Disease and Diabetes | Lifetime | 62 | CN 3 | 99.49 |
| Systemic Lupus Erythematosus Research | Lifetime | 201 | CN 4 | 99.28 |
| Vasculitis and related conditions | Lifetime | 87 | CN 3 | 98.83 |
| Ferroptosis and cancer prognosis | Lifetime | 220 | CN 100 | 97.22 |
| Natural Compounds in Disease Treatment | Lifetime | 17 | CN 7 | 97.35 |
| Dialysis and Renal Disease Management | Lifetime | 289 | CN 7 | 98.54 |
| Renal and Vascular Pathologies | Lifetime | 271 | CN 3 | 98.18 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 191 | CN 2 | 97.49 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 509 | CN 5 | 98.05 |
| Folate and B Vitamins Research | Lifetime | 767 | CN 24 | 95.26 |
| Renal and related cancers | Lifetime | 975 | CN 35 | 96.01 |
| Autoimmune Bullous Skin Diseases | Lifetime | 621 | CN 9 | 95.92 |
| Complement system in diseases | Lifetime | 589 | CN 10 | 95.36 |
| Genetic and Kidney Cyst Diseases | Lifetime | 493 | CN 23 | 94.17 |
| Parathyroid Disorders and Treatments | Lifetime | 907 | CN 13 | 95.29 |
| Lipid metabolism and disorders | Lifetime | 585 | CN 20 | 94.29 |
| Traditional Chinese Medicine Studies | Lifetime | 485 | CN 295 | 91.37 |
| Liver Diseases and Immunity | Lifetime | 714 | CN 18 | 94.88 |
| Acupuncture Treatment Research Studies | Lifetime | 597 | CN 215 | 92.44 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 151 | CN 20 | 89.72 |
| Phytochemistry and biological activity of medicinal plants | Lifetime | 261 | CN 55 | 88.87 |
| Advanced Decision-Making Techniques | Lifetime | 852 | CN 764 | 80.86 |
| Analytic and geometric function theory | Lifetime | 422 | CN 45 | 88.26 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 13 | CN 2 | 99.45 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 202 | CN 18 | 96.89 |
| MicroRNA in disease regulation | 2021-2025 | 701 | CN 426 | 93.00 |
| Ferroptosis and cancer prognosis | 2021-2025 | 666 | CN 564 | 92.11 |
| Epigenetics and DNA Methylation | 2021-2025 | 965 | CN 356 | 90.24 |
| Renal and related cancers | 2021-2025 | 386 | CN 34 | 89.85 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 441 | CN 75 | 90.72 |
| Renal cell carcinoma treatment | 2021-2025 | 956 | CN 137 | 88.04 |
| Vasculitis and related conditions | 2021-2025 | 417 | CN 26 | 87.17 |
| Cell Adhesion Molecules Research | 2021-2025 | 336 | CN 43 | 81.64 |
| Circular RNAs in diseases | 2021-2025 | 983 | CN 704 | 85.27 |
| Platelet Disorders and Treatments | 2021-2025 | 521 | CN 50 | 86.62 |
| interferon and immune responses | 2021-2025 | 764 | CN 425 | 82.62 |
| Hormonal Regulation and Hypertension | 2021-2025 | 586 | CN 54 | 85.04 |
| Renal and Vascular Pathologies | 2021-2025 | 543 | CN 23 | 81.85 |
| Genetic and Kidney Cyst Diseases | 2021-2025 | 302 | CN 45 | 82.20 |
| Lipid metabolism and disorders | 2021-2025 | 391 | CN 90 | 74.72 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 923 | CN 43 | 71.32 |
| Bone Metabolism and Diseases | 2021-2025 | 906 | CN 406 | 70.10 |
| Phagocytosis and Immune Regulation | 2021-2025 | 766 | CN 324 | 68.69 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 999 | CN 324 | 65.78 |
| Dermatological and Skeletal Disorders | 2021-2025 | 303 | CN 17 | 65.23 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 799 | CN 208 | 39.93 |
| Apelin-related biomedical research | 2021-2025 | 730 | CN 142 | 33.56 |
| Analytic and geometric function theory | 2021-2025 | 835 | CN 108 | 23.57 |
